
Location Sciences Group PLC, founded in 2005 and headquartered in Cheltenham, United Kingdom, is a global specialist in location data and data intelligence. The company develops advanced platform products aimed at enhancing the precision and integrity of location-based advertising and analytics. Its key offerings include Verify, an independent and proprietary verification platform that rigorously authenticates the quality and accuracy of location-targeted advertising data for various sectors, such as automotive, retail, quick-service restaurants, grocery, consumer packaged goods, and travel and hospitality. Furthermore, GeoProtect enables brands, agencies, and suppliers to validate the reliability of audience segments derived from location information. The company also offers a dedicated data and insights platform, providing access to critical location data points. Location Sciences Group PLC delivers these specialized solutions to advertisers, agencies, and suppliers worldwide. The company previously operated as Proxama Plc before adopting its current name in March 2018.
Location Sciences Group PLC trades as LSAI.L on LSE. The company is classified in Technology / Software - Application and reports in GBP.
The current profile places the business in Software - Application. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows £53,066 of revenue and -£1.72M of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Location Sciences Group PLC can be compared against peers such as Catenae Innovation Plc, Edenville Energy Plc, Microsaic Systems plc, Omega Diagnostics Group PLC, Vela Technologies PLC.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of £9,108, beta of 0.56, and return on equity of -64.9%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
LSAI.L currently shows total debt of £0 and beta of 0.56. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.locationsciences.ai
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.